Trials / Completed
CompletedNCT03356964
Step Down FSH Approach and Late Follicular Phase in Progesterone Level
Impact of Step-down Approach During Late Follicular Phase in Recombinant FSH-stimulation Dosage for IVF on Progesterone Level on the Day of Final Oocyte Maturation
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- ART Fertility Clinics LLC · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Step-down approach and late follicular phase progesterone level
Detailed description
The study will be performed using the stimulation medication Gonal-F which is a recombinant FSH-preparation. Due to application as pen-device, it allows reduction of the stimulation dosage in steps of 12.5IU. It is important to evaluate the dynamics of progesterone-rise after final oocyte maturation, as this dynamic might also have an influence on the receptivity of the endometrium.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | follicle stimulating hormone | Follicle stimulating hormone( will be chosen according to ovarian reserve parameters in the study group the dosage will be reduced in the control group it will remain unchanged |
Timeline
- Start date
- 2017-11-23
- Primary completion
- 2020-02-12
- Completion
- 2020-08-31
- First posted
- 2017-11-29
- Last updated
- 2020-09-09
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT03356964. Inclusion in this directory is not an endorsement.